About Delphi Ventures
Delphi Ventures is a Financial Services company based in Menlo Park (United States). It operates as an investments are made in life sciences firms across all stages. It operates on a B2B model. Its focus areas include Investment Industry, Venture Capital Funds, Independent Funds and Conventional VCs.
Company details
A stage-agnostic venture capital firm is operated with a focus on life sciences. Investments are directed toward companies in biopharma, medical devices, biotech, and diagnostics. Operations span the US and Canada, with the firm based in Menlo Park, United States. Portfolio holdings include Intarcia Therapeutics, TriVascular, Karyopharm Therapeutics, PTC Therapeutics, and Relypsa.
- Headquarters Menlo Park, United States
- SectorsFinancial Services
- Website delphiventures.com
Web traffic of Delphi Ventures
Websites that share an audience with Delphi Ventures (delphiventures.com).
Websites whose visitors overlap most with Delphi Ventures. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| franciscopartners.com | 79% | 47.1K | #751,938 | View details |
Top companies in Venture Capital Funds
10 companies that operate in the same segment as Delphi Ventures (Venture Capital Funds), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Network connecting investors to startups, venture capital funds, and alternatives | 2013 | Jerusalem, Jerusalem District, Israel | USD 35 M | – | – | |
Venture capital firm investing in early-stage tech startups | 1972 | Menlo Park, California, United States | – | – | – | |
Venture capital investments and support for entrepreneurs in technology and innovation sectors. | 1911 | Redwood City, California, United States | – | USD 691.23 K | – | |
Accel is recognized as a leading venture capital firm. | 1983 | Palo Alto, California, United States | – | – | – | |
Early-stage startup ecosystem is supported by Venture Catalysts in India. | 2015 | Mumbai, Maharashtra, India | – | USD 3.32 M | – | |
Venture capital investing in innovative companies across global sectors is undertaken by Lightspeed Venture Partners. | 1997 | Menlo Park, California, United States | – | – | 42 | |
Venture capital fund and startup incubator for healthcare and agricultural companies | 1993 | Misgav, Northern District, Israel | – | USD 1.99 M | 23 | |
Management consulting services are provided to organizations worldwide. | 1965 | Brisbane, Queensland, Australia | – | – | – | |
Multiple sectors are invested in by this venture capital firm. | 1987 | Sao Paulo, Brazil | – | USD 715.62 M | – | |
Early-stage startups are funded by this venture capital firm. | 2004 | Menlo Park, California, United States | – | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Delphi Ventures
Complete news archive for Delphi Ventures
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Delphi Ventures
Delphi Ventures is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
A stage-agnostic venture capital firm is operated with a focus on life sciences. Investments are directed toward companies in biopharma, medical devices, biotech, and diagnostics. Operations span the US and Canada, with the firm based in Menlo Park, United States. Portfolio holdings include Intarcia Therapeutics, TriVascular, Karyopharm Therapeutics, PTC Therapeutics, and Relypsa.